Clever Culture Systems Secures Two Orders for Imaging Instrument

MT Newswires Live

May 28

Clever Culture Systems (ASX:CC5) secured two new pharmaceutical orders, including an agreement for a paid evaluation of its APAS Independence imaging instrument with a new pharmaceutical customer, according to a Thursday filing with the Australian bourse.

The agreement includes an upfront payment covering installation, which is expected in June, and a non-refundable prepayment for a potential purchase following the evaluation, the company said.

The second purchase order is from a new single-site US customer. The instrument under the second order has been shipped and is also due to be installed in June.

Clever Culture said the volume of active global top-20 pharma customers deploying APAS increased in fiscal year 2026 and is expected to grow further in fiscal year 2027.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2638630136"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2638630136\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2638630136?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 08:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638630136","market":"nz","top_or_hot":-1,"title":"Clever Culture Systems Secures Two Orders for Imaging Instrument","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/CC5.AU\">Clever Culture</a> Systems (ASX:CC5) secured two new pharmaceutical orders, including an agreement for a paid evaluation of its APAS Independence imaging instrument with a new pharmaceutical customer, according to a Thursday filing with the Australian bourse.</p><p>The agreement includes an upfront payment covering installation, which is expected in June, and a non-refundable prepayment for a potential purchase following the evaluation, the company said.</p><p>The second purchase order is from a new single-site US customer. The instrument under the second order has been shipped and is also due to be installed in June.</p><p>Clever Culture said the volume of active global top-20 pharma customers deploying APAS increased in fiscal year 2026 and is expected to grow further in fiscal year 2027.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clever Culture Systems Secures Two Orders for Imaging Instrument</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClever Culture Systems Secures Two Orders for Imaging Instrument\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-28 08:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/CC5.AU\">Clever Culture</a> Systems (ASX:CC5) secured two new pharmaceutical orders, including an agreement for a paid evaluation of its APAS Independence imaging instrument with a new pharmaceutical customer, according to a Thursday filing with the Australian bourse.</p><p>The agreement includes an upfront payment covering installation, which is expected in June, and a non-refundable prepayment for a potential purchase following the evaluation, the company said.</p><p>The second purchase order is from a new single-site US customer. The instrument under the second order has been shipped and is also due to be installed in June.</p><p>Clever Culture said the volume of active global top-20 pharma customers deploying APAS increased in fiscal year 2026 and is expected to grow further in fiscal year 2027.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2638630136","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638630136","pubTimestamp":1779929140,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Clever Culture Systems  secured two new pharmaceutical orders, including an agreement for a paid evaluation of its APAS Independence imaging instrument with a new pharmaceutical customer, according to a Thursday filing with the Australian bourse.The agreement includes an upfront payment covering installation, which is expected in June, and a non-refundable prepayment for a potential purchase following the evaluation, the company said.The second purchase order is from a new single-site US customer. The instrument under the second order has been shipped and is also due to be installed in June.Clever Culture said the volume of active global top-20 pharma customers deploying APAS increased in fiscal year 2026 and is expected to grow further in fiscal year 2027.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","CC5.AU":"Clever Culture Systems Ltd"},"translate_title":"Clever Culture Systems获得两份成像仪器订单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CC5.AU":1},"content_text":"Clever Culture Systems (ASX:CC5) secured two new pharmaceutical orders, including an agreement for a paid evaluation of its APAS Independence imaging instrument with a new pharmaceutical customer, according to a Thursday filing with the Australian bourse.The agreement includes an upfront payment covering installation, which is expected in June, and a non-refundable prepayment for a potential purchase following the evaluation, the company said.The second purchase order is from a new single-site US customer. The instrument under the second order has been shipped and is also due to be installed in June.Clever Culture said the volume of active global top-20 pharma customers deploying APAS increased in fiscal year 2026 and is expected to grow further in fiscal year 2027.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}